巴黎生物技术初创公司Aqemia正在利用人工智能和量子计算技术快速设计和发现新药物。该公司最近完成了3000万欧元的A轮融资,用于推动其药物发现平台的开发。投资方看好Aqemia利用人工智能加速药物设计的前景。
Title: Biotech startup’s AI drug discovery attracts funding
Keywords: Biotechnology, AI, Drug discovery
News content: Paris-based biotech startup Aqemia is leveraging AI and quantum computing to rapidly design and discover new drugs. The company recently closed a €30 million Series A funding to boost development of its drug discovery platform. Investors are bullish about Aqemia’s prospects of using AI to accelerate drug design.
【来源】https://sifted.eu/articles/aqemia-60m-series-a
Views: 1